Morrow; Ardythe L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morrow; Ardythe L..The latest application filed is for "treatment of inflammatory bowel diseases with 2'-fucosyllactose compounds".

Company Profile

6.16.19

Morrow; Ardythe L. - Cincinnati OH
Morrow; Ardythe L. - Cincinnatti OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fucosylated oligosaccharides for prevention of coronavirus infection Grant 11,331,329 - Morrow , et al. May 17, 2	2022-05-17
Inhibiting inflammation with milk oligosaccharides Grant 11,324,765 - Morrow , et al. May 10, 2	2022-05-10
2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation Grant 11,324,766 - Morrow , et al. May 10, 2	2022-05-10
Treatment Of Inflammatory Bowel Diseases With 2'-fucosyllactose Compounds App 20220133758 - MORROW; Ardythe L. ; et al.	2022-05-05
2'-fucosyllactose For The Prevention And Treatment Of Coronavirus-induced Inflammation App 20210353653 - Morrow; Ardythe L. ; et al.	2021-11-18
Fucosylated Oligosaccharides For Prevention Of Coronavirus Infection App 20210353654 - Morrow; Ardythe L. ; et al.	2021-11-18
Inhibiting Inflammation With Milk Oligosaccharides App 20210283155 - Morrow; Ardythe L. ; et al.	2021-09-16
Inhibiting inflammation with milk oligosaccharides Grant 11,058,697 - Morrow , et al. July 13, 2	2021-07-13
Use of oligosaccharide compositions to enhance weight gain Grant 10,857,167 - Morrow , et al. December 8, 2	2020-12-08
Use Of Glycans And Glycosyltransferases For Diagnosing/monitoring Inflammatory Bowel Disease App 20200308644 - MORROW; Ardythe L. ; et al.	2020-10-01
Treatment Of Inflammatory Bowel Diseases With 2'-fucosyllactose Compounds App 20200129534 - MORROW; Ardythe L. ; et al.	2020-04-30
Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease Grant 10,626,460 - Morrow , et al.	2020-04-21
Inhibiting inflammation with milk oligosaccharides App 20190099435 - Morrow; Ardythe L. ; et al.	2019-04-04
Inhibiting inflammation with milk oligosaccharides Grant 10,098,903 - Morrow , et al. October 16, 2	2018-10-16
Use Of Oligosaccharide Compositions To Enhance Weight Gain App 20180153915 - MORROW; Ardythe L. ; et al.	2018-06-07
Use Of Glycans And Glycosyltransferases For Diagnosing/monitoring Inflammatory Bowel Disease App 20150376696 - Morrow; Ardythe L. ; et al.	2015-12-31
Inhibiting Inflammation With Milk Oligosaccharides App 20150306120 - Morrow; Ardythe L. ; et al.	2015-10-29
Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease Grant 9,132,142 - Morrow , et al. September 15, 2	2015-09-15
Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease Grant 9,132,143 - Morrow , et al. September 15, 2	2015-09-15
Inhibiting inflammation with milk oligosaccharides Grant 9,034,847 - Morrow , et al. May 19, 2	2015-05-19
Use Of Secretor, Lewis And Sialyl Antigen Levels In Clinical Samples As Predictors Of Risk For Disease App 20150079055 - Morrow; Ardythe L. ; et al.	2015-03-19
Use of Secretor, Lewis and Sialyl Antigen Levels in Clinical Samples as Predictors of Risk for Disease App 20140140970 - Morrow; Ardythe L. ; et al.	2014-05-22
Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease Grant 8,574,850 - Morrow , et al. November 5, 2	2013-11-05
Adiponectin for treatment of various disorders Grant 8,314,061 - Morrow , et al. November 20, 2	2012-11-20
Inhibiting Inflammation With Milk Oligosaccharides App 20120202753 - Morrow; Ardythe L. ; et al.	2012-08-09
Oligosaccharide Compositions And Use Thereof In The Treatment Of Infection App 20110207659 - Morrow; Ardythe L. ; et al.	2011-08-25
Use Of Secretor, Lewis And Sialyl Antigen Levels In Clinical Samples As Predictors Of Risk For Disease App 20110177035 - Morrow; Ardythe L. ; et al.	2011-07-21
Oligosaccharide compositions and use thereof in the treatment of infection Grant 7,893,041 - Morrow , et al. February 22, 2	2011-02-22
Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease Grant 7,871,785 - Morrow , et al. January 18, 2	2011-01-18
Rapid Lateral Flow Glycan-detecting Device App 20100279308 - Morrow; Ardythe L. ; et al.	2010-11-04
Adiponectin For Treatment Of Various Disorders App 20090197806 - Morrow; Ardythe L. ; et al.	2009-08-06
Use of Secretor, Lewis and Sialyl Antigen Levels in Clinical Samples as Predictors of Risk for Disease App 20090191551 - Morrow; Ardythe L. ; et al.	2009-07-30
Oligosaccharide Compositions and Use Thereof in the Treatment of Infection App 20070275881 - Morrow; Ardythe L. ; et al.	2007-11-29

Company Registrations

NCAGE Code	48BT4	MORROW ARDYTHE L
CAGE Code	48BT4	MORROW, ARDYTHE L
DUNS	611018677	MORROW, ARDYTHE L

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.